External broker reports(aggregated public sources), Axis Direct

Axis Direct

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Long-term demand remains resilient: The long-term demand scenario for the IT sector remains strong, and it is expected to regain momentum in H2FY25 and beyond.</li><li>However, near-term demand remains uncertain, leading to ambiguity around growth momentum in the immediate future.</li><li>Secured deals to support medium-term demand momentum: The management remains confident of gaining medium-term demand momentum, supported by the deals it secured in previous quarters. </li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Long-term demand remains resilient: The long-term demand scenario for the IT sector remains strong, and it is expected to regain momentum in H2FY25 and beyond.However, near-term demand remains uncertain, leading to ambiguity around growth momentum in the immediate future.Secured deals to support medium-term demand momentum: The management remains confident of gaining medium-term demand momentum, supported by the deals it secured in previous quarters. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HCL Technologies - Strong Results; Better Execution

External broker reports(aggregated public sources), Prabhudas Lilladhar

Prabhudas Lilladhar

Prabhudas Lilladher is one of India's leading research based financial services organisation.

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>We attended investor day of HCLT, the management was confident of continued executions of strong operating performance while having offered service lines within a scope of both discretionary and non-discretionary front.</li><li>It is aspiring to grow its topline by double-digit for the next five years, while improving its TCV run-rate and going beyond the current offerings where the participation is currently suboptimal.</li><li>While leveraging GenAI solutions, the company is gaining higher mind-share and wallet-share on the back of passing on efficiency and productivity benefits to clients and in return deriving higher scope of work.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We attended investor day of HCLT, the management was confident of continued executions of strong operating performance while having offered service lines within a scope of both discretionary and non-discretionary front.It is aspiring to grow its topline by double-digit for the next five years, while improving its TCV run-rate and going beyond the current offerings where the participation is currently suboptimal.While leveraging GenAI solutions, the company is gaining higher mind-share and wallet-share on the back of passing on efficiency and productivity benefits to clients and in return deriving higher scope of work.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HCL Technologies - Chasing for Robust and Sustainable Execution

External broker reports(aggregated public sources), Motilal Oswal Financial Services Limited

Motilal Oswal

Motilal Oswal Financial Services Limited

Motilal Oswal Financial Services Limited is an Indian diversified financial services firm offering a range of financial products and services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>We attended HCLT’s Investor Day 2024 wherein the management outlined its strategic objectives and showcased its capabilities in GenAI.</li><li>We believe HCLT’s go-to-market (GTM) strategy, which combines its IT Services and ER&amp;D business offerings, gives HCLT an edge over its peers.</li><li>We also witnessed signs of improvement in the demand environment in financial services.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

We attended HCLT’s Investor Day 2024 wherein the management outlined its strategic objectives and showcased its capabilities in GenAI.We believe HCLT’s go-to-market (GTM) strategy, which combines its IT Services and ER&amp;D business offerings, gives HCLT an edge over its peers.We also witnessed signs of improvement in the demand environment in financial services.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

HCL Technologies - HCLT Investor Day 2024: Engineering Growth

APAC IPOs & Placements, Aequitas Research

Akshat Shah

APAC IPOs & Placements

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

SAI Life Sciences / Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/sai-life-sciences" target="_blank" data-smartkarma-citation="entities:43724:1" rel="noopener">SAI Life Sciences (SAILS12 IN)</a> raised around US$360m in its India IPO in Dec 2024. The lockup on its pre-IPO investors is set to expire soon.</li>
<li>Sai Life Sciences is a contract research, development and manufacturing organisation providing end-to-end services across drug discovery, development and manufacturing value-chain, for small to global pharmaceutical innovators and biotechnology firms.</li>
<li>In this note, we will talk about the lockup dynamics and possible placement.</li>
</ul>



SAI Life Sciences (SAILS12 IN) raised around US$360m in its India IPO in Dec 2024. The lockup on its pre-IPO investors is set to expire soon.
Sai Life Sciences is a contract research, development and manufacturing organisation providing end-to-end services across drug discovery, development and manufacturing value-chain, for small to global pharmaceutical innovators and biotechnology firms.
In this note, we will talk about the lockup dynamics and possible placement.


Sai Life Sciences IPO Lockup - US$840m Lockup Release; TPG Asia up 5.8x with a 24.8% Stake

<ul>
<li>
<a href="https://www.smartkarma.com/entities/oswal-pumps" target="_blank" data-smartkarma-citation="entities:43952:1" rel="noopener">Oswal Pumps (1019841D IN)</a> is looking to raise about US$162m in its upcoming India IPO. The deal has been downsized from an earlier size of around US$250m.</li>
<li>Oswal Pumps Ltd (OPL) specializes in the manufacturing of solar-powered and conventional pumps, electric motors, and related components for agricultural, residential, and industrial applications.</li>
<li>We have looked at the company’s past performance in our previous notes. In this note, we will talk about the RHP updates and IPO valuations.</li>
</ul>



Oswal Pumps (1019841D IN) is looking to raise about US$162m in its upcoming India IPO. The deal has been downsized from an earlier size of around US$250m.
Oswal Pumps Ltd (OPL) specializes in the manufacturing of solar-powered and conventional pumps, electric motors, and related components for agricultural, residential, and industrial applications.
We have looked at the company’s past performance in our previous notes. In this note, we will talk about the RHP updates and IPO valuations.


Oswal Pumps IPO - RHP Updates & Thoughts on Peer Comp and Valuation

India

HCL Technologies Limited provides software development and related engineering services.  The Group's technologies utilize a variety of technologies, including Internet and e-commerce, networking, internet telephony, embedded software, ASIC/VLSI design and testing, satellite and wireless communications, and component based object technologies, including COM, DCOM and COBRA.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

HCL Technologies (HCLT IN)

HCL Technologies - Strong Results; Better Execution

Long-term demand remains resilient: The long-term demand scenario for the IT sector remains strong, and it is expected to regain momentum in H2FY25...

Axis Direct

HCL Technologies - Chasing for Robust and Sustainable Execution

We rollover our estimates and introduce FY27 with USD revenue and INR PAT CAGR of 10.9% and 12.9% over FY25E-FY27E. Maintain BUY with a revised...

Prabhudas Lilladhar